About Interferon-related developmental regulator 2
Interferon-related developmental regulator 2 (IFRD2) is a protein
from Homo sapiens identified by UniProt accession
Q12894, 442 residues long.
MolForge cross-references it against 0 known binders and
35 disease associations.
Target properties
| Protein name | Interferon-related developmental regulator 2 |
| UniProt accession | Q12894 |
| Gene | IFRD2 |
| Organism | Homo sapiens |
| Length | 442 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (35)
Diseases linked to this target (Open Targets).
- reticulocyte count · score 0.65
- reticulocyte measurement · score 0.65
- Immature Reticulocyte Fraction Measurement · score 0.60
- mean reticulocyte volume · score 0.45
- basophil count · score 0.09
- blood protein measurement · score 0.07
- basophil percentage of leukocytes · score 0.07
- serum urea measurement · score 0.06
- mean corpuscular volume · score 0.05
- schizophrenia · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q12894-F1 | alphafold | PREDICTED | 85.06 | — |
Amino-acid sequence (442 residues)
MPRARKGNTL RKGGQRRGGG ARSSAQADSG SSDDEAASEA RSTASECPSL LSTTAEDSLG GDVVDEQGQQ EDLEEKLKEY VDCLTDKSAK TRQGALESLR LALASRLLPD FLLERRLTLA DALEKCLKKG KGEEQALAAA VLGLLCVQLG PGPKGEELFH SLQPLLVSVL SDSTASPAAR LHCASALGLG CYVAAADIQD LVSCLACLES VFSRFYGLGG SSTSPVVPAS LHGLLSAALQ AWALLLTICP STQISHILDR QLPRLPQLLS SESVNLRIAA GETIALLFEL ARDLEEEFVY EDMEALCSVL RTLATDSNKY RAKADRRRQR STFRAVLHSV EGGECEEEIV RFGFEVLYMD SWARHRIYAA FKEVLGSGMH HHLQNNELLR DIFGLGPVLL LDATALKACK VPRFEKHLYN AAAFKARTKA RSRVRDKRAD IL
Explore Interferon-related developmental regulator 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets